Elos Medtech Interim Report January 1 - June 30, 2018
Rising demand and expansion in USA April – June 2018 · Net sales for the second quarter of the year increased and amounted to SEK 166.0 M (155.6), corresponding to organic growth of 6.7%. Adjusted for currency fluctuations the growth was 5.8%. · Operating profit was SEK 5.2 M (13.5). The operating margin was 3.1% compared to 8.7% in 2017. The operating profit has been negatively impacted by non-recurring costs amounted to SEK 5.6 million. · Profit after net financial items amounted to SEK 5.2 M (5.9). Net financial items were positively impacted by exchange rate